Печень в норме: программа очищения и восстановления печени при явных и скрытых заболеваниях - Кристин Киркпатрик

Raghu, S. H. Lin, S. Y. Wang, C. H. Kuo, Y. J. Tseng, and L. Y. Sheen.2013. «Metabolomics of Ginger Essential Oil Against Alcoholic Fatty Liverin Mice.» Journal of Agricultural and Food Chemistry 61 (46) (November 20): 11231–40.

Liu, W., S. S. Baker, R. D. Baker, and L. Zhu. 2015. «Antioxidant Mechanismsin Nonalcoholic Fatty Liver Disease.» Current Drug Targets 16 (12): 1301–14.

Loguercio, C., A. Federico, C. Tuccillo, F. Terracciano, M. V. D’Auria, C. De Simone, and C. Del Vecchio Blanco. 2005. «Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases.» Journal of Clinical Gastroenterology 39 (6) (July): 540–43.

Loomba, R., C. B. Sirlin, J. B. Schwinner, and J. E. Lavine. 2009. «Advances inPediatric Nonalcoholic Fatty Liver Disease.» Hepatology 50 (4) (October): 1282–93.

Lustig, R. H., L. A. Schmidt, and C. D. Brindis. 2012. «Public Health: The ToxicTruth About Sugar.» Nature 482 (February 2): 27–29.

Ma, J., C. S. Fox, P. F. Jacques, E. K. Speliotes, U. Hoffmann, C. E., Smith, E. Saltzman, and N. M. McKeown. 2015. «Sugar-Sweetened Beverage, Diet Soda, and Fatty Liver Disease in the Framingham Heart Study Cohorts.»Journal of Hepatology 63 (2) (August): 462–69.

Ma, Y. Y., L. Li, C. H. Yu, Z. Shen, L. H. Chen, and Y. M. Li. 2013. «Effects of Probiotics on Nonalcoholic Fatty Liver Disease: A Meta-analysis.» World Journal of Gastroenterology 19 (40) (October 28): 6911–18.

Malaguarnera, G., E. Cataudella, M. Giordano, G. Nunnari, G. Chisari, andM. Malaguarnera. 2012. «Toxic Hepatitis in Occupational Exposure to Solvents.» World Journal of Gastroenterology 18 (22) (June 14): 2756–66.

Malaguarnera, M., M. Vacante, T. Antic, M. Giordano, G. Chisari, R. Acquaviva,S. Mastrojeni, G. Malaguarnera, A. Mistretta, G. Li Volti, and F. Galvano. 2012. «Bifidobacterium longum with Fructo-oligosaccharides in Patients with Non Alcoholic Steatohepatitis.» Digestive Diseases and Sciences 57 (2)(February): 545–53.

Mandayam, S., M. M. Jamal, and T. R. Morgan. 2004. «Epidemiology of Alcoholic Liver Disease.» Seminars in Liver Disease 24 (3) (August): 217–32.

Marikar, S., and L. Ferran. 2008. «Exclusive: Jeremy Piven Defends Play Departure Due to Mercury Poisoning.» ABC News, January 15, 2008.http://abcnews.go.com/GMA/story?id=6652551.

Masterton, G. S., J. N. Plevris, and P. C. Hayes. 2010. «Review Article: Omega-3Fatty Acids–A Promising Novel Therapy for Non-alcoholic Fatty Liver Disease.» Alimentary Pharmacology & Therapeutics 31 (7): 679–692.

Mathurin, P., A. Hollebecque, L. Arnalsteen, D. Buob, E. Leteurtre, R. aiazzo, M. Pigeyre, H. Verkindt, S. Dharancy, A. Louvet, M. Romon, and F. Pattou.2009. «Prospective Study of the Long-Term Effects of Bariatric Surgery On Liver Injury in Patients Without Advanced Disease.» Gastroenterology 137 (2) (August): 532–40.

Midanik, L. T. 1988. «Validity of Self-Reported Alcohol Use: A Literature Reviewand Assessment.» British Journal of Addiction 83 (9) (September): 1019–30.

Miyake, T., T. Kumagi, M. Hirooka, S. Furukawa, K. Kawasaki, M. Koizumi,Y. Todo, S. Yamamoto, H. Nunoi, Y. Tokumoto, Y. Ikeda, M. Abe, K. Kitai, B.Matsuura, and Y. Hiasa. 2015. «Significance of Exercise in NonalcoholicFatty Liver Disease in Men: A Community-Based Large Cross-sectionalStudy.» Journal of Gastroenterology 50 (2) (February): 230–37.

Mozaffarian, D., T. Hao, E. R. Rimm, W. C. Willett, and F. B. Hu. 2012. «Changesin Diet and Lifestyle and Long-Term Weight Gain in Women and Men.» NewEngland Journal of Medicine 364: 2392–2404.

Mudipalli, A. «Lead Hepatoxicity & Potential Health Effects.» 2007. IndianJournal of Medical Research 126 (6) (December): 518–27.

Muraki, E., Y. Hayashi, H. Chiba, N. Tsunoda, and K. Kasono. 2011. «Dose-Dependent Effects, Safety and Tolerability of Fenugreek in Diet-Induced Metabolic Disorders in Rats.» Lipids in Health and Disease 10:240. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292492/.

Murase, T., A. Nagasawa, J. Suzuki, T. Hase, and I. Tokimitsu. 2002. «BeneficialEffects of Tea Catechins on Diet-Induced Obesity: Stimulation of Lipid Catabolism in the Liver.» International Journal of Obesity 26 (11) (November): 1459–64.

Musso, G., R. Gambino, M. Cassader, and G. Pagano. 2010. «A Meta-analysis ofRandomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease.» Hepatology 52: 79–104.

Nabavi, S. F., M. Daglia, A. H. Moghaddam, S. Habtemariam, and S. M. Nabavi.2014. «Curcumin and Liver Disease: from Chemistry to Medicine.» Comprehensive Reviews in Food Science and Food Safety 13 (1) (January): 62–77.

National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. http://livertox.nlm.nih.gov/.

Nishioji, K., N. Mochizuki, M. Kobayashi, M. Kamaguchi, Y. Sumida, T.Nishimura, K. Yamaguchi, H. Kadotani, and Y. Itoh. 2015. «The Impact ofPNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg After Age20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.» PLoS One 20 (10) (October 20): e0140427.

«Nonalcoholic Fatty Liver: The New Face of Metabolic Syndrome.» 2015. MayoClinic Health Letter 33 (2) (February): 1–3.

Noone, T. C., R. C. Semelka, D. M. Chaney, and C. Reinhold. 2004. «AbdominalImaging Studies: Comparison of Diagnostic Accuracies Resulting from Ultrasound, Computed Tomography, and Magnetic Resonance Imaging in theSame Individual.» Magnetic Resonance Imaging 22 (1) (January): 19–24.

Oh, S., T. Shida, K. Yamagishi, K. Tanaka, R. So, T. Tsujimoto, and J. Shoda. 2015. «Moderate to Vigorous Physical Activity Volume Is an Important Factor for Managing Nonalcoholic Fatty Liver Disease: A Retrospective Study.» Hepatology 61 (4) (April): 1205–15.

Oh, S., K. Tanaka, E. Warabi, and J. Shoda. 2013. «Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases.» Medicine andScience in Sports and Exercise 45 (12) (December): 2214–22.

Okla, M., I. Kang, D. M. Kim, V. Gourineni, N. Shay, L. Gu, and S. Chung. 2015. «Ellagic Acid Modulates Lipid Accumulation in Primary Human Adipocytesand Human Hepatoma Huh7 cells via Discrete Mechanisms.» Journal of Nutritional Biochemistry 26 (1) (January): 82–90.

Oldways Preservation & Exchange Trust. Learn more about Oldways and theMediterranean diet at www.oldwayspt.org

Ouyang, X., P. Cirillo, Y. Sautin, S. McCall, J. L. Bruchette, A. M. Diehl, R. J. Johnson, and M. J. Abdelmalek. 2008. «Fructose Consumption as a Risk Factorfor Non-alcoholic Fatty Liver Disease.» Journal of Hepatology 48 (6) (June): 993–99.

Paolella, G., C. Mandato, L. Pierri, M. Poeta, M. DiStasi, and P. Vajro. 2014. «GutLiver Axis and Probiotics: Their Role in Non-alcoholic Fatty Liver Disease.»World Journal of Gastroenterology 20 (42) (November 14): 15518–31.

Parker, H. M., N. A. Johnson, C. A. Burdon, J. S. Cohn, H. T. O’Connor, and J.George. 2012. «Omega-3 Supplementation and Non-alcoholic Fatty Liver Disease: A Systematic Review